How Ozempic and Wegovy became globally recognized brands to treat obesity | DW News

For years, the standard medical advice to treat obesity was to eat less and to exercise more. But new drugs like Ozempic and Wegovy have become globally recognized brands, because they offer an alternative - and for many, an easier - way to lose weight. Now, the World Health Organization is endorsing those drugs – referred to as GLP-1 therapies – as effective treatments for obesity. It says the condition should be treated as a chronic, relapsing disease, but emphasizes that medication is not the only solution. 00:00 WHO endorses drugs to treat obesity 01:23 Francesca Celletti, WHO Senior Obesity Adviser For more news go to: http://www.dw.com/en/ Follow DW on social media: ►Instagram: https://www.instagram.com/dwnews ►TikTok: https://www.tiktok.com/@dwnews ►Facebook: https://www.facebook.com/deutschewellenews/ ►Twitter: https://twitter.com/dwnews Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1 #obesity #treatment #who